— Know what they know.
Not Investment Advice

ZVRA NASDAQ

Zevra Therapeutics, Inc.
1W: -10.0% 1M: +0.0% 3M: +19.2% YTD: +25.8% 1Y: +21.8% 3Y: +124.6% 5Y: +15.2%
$10.03
-0.46 (-4.39%)
 
Weekly Expected Move ±7.5%
$9 $10 $11 $12 $13
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 51 · $592.9M mcap · 55M float · 2.25% daily turnover · Short 55% of daily vol

📊 Key Metrics

TTM
$122M
Revenue
+201.3% YoY
$124M
Net Income
+235.0% YoY
$12M
Free Cash Flow
+119.4% YoY
93.7%
Gross Margin
24.4%
Op. Margin
104.6%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE127.8%
ROA53.7%
ROIC-169.1%

Valuation

P/E4.7
P/B2.8
EV/EBITDA4.1

Leverage

Debt/Equity0.41
Current Ratio5.68
Interest Cov.24.1x

Quality Scores

Piotroski F7/9
Altman Z2.92
Beneish M0.22

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms